Where DLH stands after its latest 10-Q
Revenue for the twelve months to June 2026 was $254m, down 29.5% on a year earlier, a steeper fall than the 22.4% decline a quarter earlier. That puts it 33 of 34 for growth among the health care services companies we cover. Free-cash-flow margin fell to 5.5% from 6.8% a year earlier. Operating margin narrowed to -0.1% from 5.8%. The diluted share count is up 2.2% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades D. It passes 0 of our 7 financial-health checks.
Our model value for DLH Holdings is under review, so past values are not shown until it is resolved.
Source: 10-Q filed July 29, 2026 on SEC EDGAR · Financials · Valuation